Bioorganic and bioinorganic chemistry by Constable, Edwin C. et al.
846  CHIMIA 2010, 64, No. 12  550th AnniversAry of the University of BAsel
doi:10.2533/chimia.2010.846   Chimia 64 (2010) 846–854  © Schweizerische Chemische Gesellschaft
*Correspondence: Prof. E. C. Constable, 
Prof. C. E. Housecroft
Department of Chemistry
University of Basel 
Spitalstrasse 51
CH-4056 Basel
E-mail: edwin.constable@unibas.ch,  
catherine.housecroft@unibas.ch
*Dr. M. Creus
Department of Chemistry
University of Basel 
Spitalstrasse 51
CH-4056 Basel
E-mail: marc.creus@unibas.ch
*Prof. K. Gademann
Department of Chemistry
St. Johanns-Ring 19
CH-4056 Basel
E-mail: karl.gademann@unibas.ch
*Prof. B. Giese
Department of Chemistry
St. Johanns-Ring 19
CH-4056 Basel
E-mail: bernd.giese@unibas.ch
*Prof. T. R. Ward
Department of Chemistry
University of Basel 
Spitalstrasse 51
CH-4056 Basel
E-mail: thomas.ward@unibas.ch
*Prof. W.-D. Woggon, Prof. A. Chougnet
Department of Chemistry
St. Johanns-Ring 19
CH-4056 Basel
E-mail: wolf-d.woggon@unibas.ch,  
antoinette.chougnet@unibas.ch
Bioorganic and Bioinorganic Chemistry
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Abstract: The interdisciplinary projects in bioinorganic and bioorganic chemistry of the Department of Chemistry, 
University of Basel led to the preparation of new systems that mimic biologically important processes and to the 
discovery of compounds from natural sources which are very promising with respect to medical applications. The 
advances in these areas are reported here.
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The Constable-Housecroft group is in-
volved in biomimetic and bioinspired 
chemistry primarily relating to the fun-
damental processes in nature with a target 
of designing functional systems of suffi-
cient robustness for practical application. 
This overview concentrates upon chemi-
cal approaches to the splitting of water 
into H2 and O2 based upon biomimetic 
or bioinspired principles. Other activi-
ties within the group involve the tagging 
of biomolecules with luminescent metal 
complexes for intracellular studies (with 
Prof. Matthias Wymann, Department 
of Biomedicine) and the deployment of 
nanoparticles functionalised with laccase 
for water purification (with Prof. Uwe 
Pieles, FHNW). The group has adopted a 
general strategy of mimicking the biolog-
ical membrane by using two-dimensional 
control of the self-assembly of multiple 
components at solid–liquid or solid–air 
interfaces.
The ultimate aim for energy produc-
tion is a coupled water-splitting reaction 
using solar energy to generate H2 and O2 
followed by recombination of the two 
diatomics in a fuel cell. The formal pro-
cess is presented in Fig. 1 which serves 
to highlight the features that need to be 
controlled. Water oxidation and reduc-
tion reactions will take place at spatially 
separated sites and the kinetics of charge 
separation will be critical in controlling 
the success of the devices. The device can 
be purely molecular or the oxidation and 
reduction equivalents could be holes and 
electrons in the valence and conduction 
bands of a semiconductor or a combina-
tion of both approaches.
For the water reduction process the 
group has taken inspiration from the Fe2S2 
structural motif found in Fe–Fe hydrog-
enases and invested significant synthetic 
Biomimetic Splitting of Water
Edwin C. Constable and Catherine E. Housecroft
 
Fig. 1. A general 
scheme for water 
splitting using 
solar-derived 
photons and two 
structures developed 
as biomimetic 
hydrogenase 
analogues.
550th AnniversAry of the University of BAsel  CHIMIA 2010, 64, No. 12  847
Evolutionary Rules for 
Metalloenzyme Design
Marc Creus
Current work 
within the newly-
established Creus 
group is based on 
the concept that di-
rect metal coordina-
tion to non-catalytic 
proteins may lead to 
nascent metalloen-
zymes, which can form a basis for further 
evolution. Conceptually, the dual ideas of 
‘emergence’ and ‘evolution’ of metalloen-
zymes correspond to two extremes of an 
evolutionary process: i) a qualitative step, 
involving a new function reached through 
innovation (e.g. acquisition of catalytic ac-
tivity from previously inactive form) and 
ii) a quantitative step (e.g. the improve-
ment of a weak, but detectable function). 
Directed evolution, despite its limitations 
in practical terms,[1] provides a powerful 
tool for the second type (or quantitative) 
step.[2] Although the study of intermediate 
steps of improvement of metalloenzymes 
is likely to contribute greatly to the estab-
lishment of engineering ground-rules for 
designing enzymes de novo, a major chal-
lenge remains in the first kind of evolution-
ary step (i.e. acquisition of function). 
Traditionally, the approach adopted for 
incorporation of a metal within a protein 
scaffold has depended largely on rational 
design, much like a synthetic chemist will 
design metal-ligands or prepare analogues 
(or derivatives) of a given set of ligands 
to improve their activity as homogeneous 
metal-catalysts.[3–5] However, it is widely 
accepted that the design of proteins de no-
vo to incorporate functional aspects, such 
as metal binding in a catalytically active 
form, remains a challenge. The option of 
rationally remodelling proteins toward a 
new function only marginally reduces the 
challenge, despite the distinct advantage 
that in this case only a fraction of the total 
design (e.g. the catalytic active site of an 
enzyme) must be addressed. A recent high-
profile example highlights the difficulty of 
rational enzyme design, in which directed 
evolution was required to improve the orig-
inal activity.[6] In simple terms: because de-
sign is difficult, evolution is necessary. 
To overcome the puzzle of structure–
function relationships in metalloprotein 
design the Creus group has adopted the 
general principle that one should work with 
large libraries and select and evolve those 
designs with the most attractive character-
istics. The basic principles of this approach 
should also be familiar to medicinal chem-
ists who screen large chemical libraries to 
effort in the preparation of complexes such 
as Hyd1 (Fig. 1). The Fe2S2 cluster is cova-
lently linked to a ruthenium(ii) photocen-
tre. Electron transfer from the ruthenium 
excited state leads to proton reduction and 
a sacrificial reductant is used to regenerate 
the ruthenium(ii) chromophore. In general 
these complexes proved to be accessible 
with the greatest difficulty, and when ob-
tained were very light and water sensitive.[1,2] 
The next generation system involved the 
use of TiO2 nanoparticles to support cova-
lently linked photocentres (conveniently 
available from related work on photovol-
taic cells) and Fe2S2 clusters functionalised 
with surface binding groups such as Hyd2. 
Cells prepared in this manner show a re-
duced photocurrent and bubbles are visibly 
observed when the bulk conjugate (TiO2, 
cluster, ruthenium complex) is irradiated 
in the presence of a sacrificial electrolyte. 
Current efforts are concentrating upon 
the quantification of hydrogen production 
through head-space analysis. In the course 
of these studies, and in cooperation with 
Prof. Pieles at the FHNW, a convenient 
method was developed grafting phospho-
nate complexes onto TiO2.[3] The use of the 
ester for the direct conjugation with the 
nanoparticles avoids an intermediate step 
involving hydrolysis of the ester to the free 
phosphonic acid; this has a significant syn-
thetic advantage because the hydrolysis is 
surprisingly difficult to achieve quantita-
tively, with the monoester being the usual 
product.
Oxygen and hydrogen are the Castor 
and Pollux twins of water splitting and, 
perhaps surprisingly, water oxidation is 
the most challenging. The biological oxy-
gen evolving centre (OEC) consists of a 
CaMn4O4 cluster.[4]
In ongoing work in collaboration with 
Professors Kaledin, Lian and Hill in Atlan-
ta, we are is designing novel water soluble 
photoactive ruthenium complexes such as 
the complex shown in Fig. 2 for driving 
the oxidation of water using ruthenium 
oxoclusters with persulfate as the primary 
oxidant.[5] In this work the extended ligand 
concept (see Supramolecular and Nano-
chemistry in this issue) has been used to 
develop photoactive analogues of methyl 
viologen.
Finally, the research group, in col-
laboration with Artur Braun and Thomas 
Graule at EMPA, is developing biphasic 
photoelectrochemical water oxidation 
methods using hydrothermally deposited 
and modified haematite films.
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Fig. 2. The general scheme for water oxidation using the Hill cluster and the methyl viologen 
analogue developed for this work.[5]
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Chemical Biology of 
Natural Products
Karl Gademann
A major line of in-
vestigation in the 
Gademann lab is 
the isolation and 
synthesis of natural 
products in order to 
understand biologi-
cal processes at the 
molecular level. For 
example, the anguinomycins[1] such as 1 
were prepared and it was demonstrated that 
these compounds are inhibitors of nuclear 
export (Fig. 1). These small molecules are 
able to disrupt protein/protein interactions 
between the transport protein CRM1 and 
its cargo protein.[1b] In this respect, it is 
fascinating to see that the truncated analog 
2 (red in Fig. 1) almost completely retains 
the activity of the parent natural product.[1b] 
Another research effort of the group is di-
rected towards target identification, and it 
was shown that a target of the cytotoxic 
lactone goniothalamin (3) is the exportin 
CRM1.[2] 
Scientists in the Gademann lab are also 
isolating and characterizing new metabo-
lites from natural sources (bioprospect-
ing), and, for example nostocarboline (4)[3] 
and the aerucyclamides (5),[4] were isolat-
ed from the cyanobacteria Nostoc 78-12A 
and Microcystis aeruginosa PCC7806, re-
spectively. Both compounds are active (the 
former in vivo[3c]) against Plasmodium fal-
ciparum, the parasite causing malaria.
With support of the European Young 
Investigator Award Gademann’s research 
is focused to a great extent on natural prod-
ucts that are inducing and enhancing the 
outgrowth of neurites. These investigations 
are of relevance in our aging society, as it 
has been suggested that such compounds 
might present a therapeutic approach to 
address neurodegenerative diseases. Fari-
nosone C (6), a neurotrophic metabolite 
isolated from Paecilomyces farinosus, and 
derivatives thereof have been synthesized 
and structure–activity relationships helped 
to delineate the pharmacophore of this 
compound.[5] As can be seen in Fig. 1, fari-
nosone C induces outgrowth of neurites in 
the PC-12 cellular assay. 
In many cases, natural products are 
powerful modulators of biological activity. 
To improve their use as tool compounds, 
spatial and temporal control of bioactivity 
would be desirable. Accordingly, a new 
method[6] was developed for surface im-
mobilization of natural products such as 
vancomycin based on catechol anchors.[7]
These catechols are useful for the 
chemical modification of many surfaces,[8] 
find the right inhibitor as well as familiar 
to inorganic chemists synthesizing large li-
braries of ligands for homogeneous metal-
catalysis. In all these examples, ‘hits’ are 
taken for further modification and experi-
mental testing, whereas those initial scaf-
folds that do not work are quickly aban-
doned. These are simple, but very power-
ful forms of Darwinian evolution that are 
routinely pursued in many labs.
By analogy, it was reasoned that large-
scale mutagenesis of the protein scaffold 
and selection for binding of a metal with 
an appropriate chemistry may provide 
sufficient diversity of first the coordina-
tion sphere (many with subtle variations) 
such that the ‘right’ species is found with 
some detectable catalytic activity. Further 
screening & selection of this weak activity 
may then lead to further improvement of 
the first and second-coordination spheres, 
with improved catalytic properties (Fig. 
1). Moreover, given detectable catalytic 
activity, directed evolution may also help 
to improve other factors, such as substrate 
binding.
It is evident that the design of the library 
is crucial to maximise success. On the one 
hand, small, rational libraries almost cer-
tainly miss good ‘hits’, particularly when 
we do not have an in-depth understand-
ing of structure–function relationships. 
In enantioselective catalysis, for example, 
prediction of structure–function relation-
ships is very difficult.[2] On the other hand, 
a larger design space offers more hits, al-
though it is limited in practice due to sheer 
scale and cost.
By applying techniques of molecular 
biology (e.g. in vivo selection and phage 
display) and a judicious combination of 
rational design and evolution, the Creus 
group has started screening and select-
ing routinely among hundreds of millions 
of potential protein variants, a scale cur-
rently beyond the reach of most rational 
design and traditional synthetic chemistry 
approaches (Fig. 1). These methods for 
creation of enzymes de novo will provide 
fundamental insight into the origin and 
evolution of catalytic activity of metallo-
proteins in nature. Further, this ‘bottom-
up’ approach to bioinorganic chemistry 
may prove fruitful in addressing questions 
such as: How can we improve homoge-
neous metallocatalysts, particularly to 
work efficiently in aqueous environments, 
a feat that many enzymes have achieved in 
nature? Additional practical applications 
for designed metalloproteins can also be 
envisaged, such as in sensors, cellular 
probes, molecular machines and in drug-
delivery.
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Fig. 1. Simplified overview of selection & screening of engineered metalloproteins and 
metalloenzymes. With current tools of molecular biology, an experimental selection can typically 
be carried out with libraries in excess of tens of millions of protein variants, which allows the 
testing of a large protein scaffold library. In contrast, screening (an approach familiar to many 
chemists) is typically limited in practice within the range of tens to thousands of variants or 
conditions per experiment. Consequently, screening is usually carried out using a subset of 
variants with a pre-selected activity (e.g. metal-binding). An enriched library, previously selected 
either experimentally (using molecular biology approaches) or rationally (e.g. in silico) can be 
further improved and validated by screening. In addition, both selection and screening can be 
used iteratively following further mutagenesis (back-arrow) in a genetic (evolutionary) algorithm.
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and, for example, the attachment of thin 
films of poly-ethylene glycol (PEG) al-
lowed for the prevention of aquatic bio-
fouling for over 100 days.[8a]
In addition, it was demonstrated that 
the immobilization of vancomycin by 
compounds such as 7 led to antimicrobial 
surfaces that inhibit the growth of Bacil-
lus subtilis.[9] This might be of clinical 
relevance, as nosocomial infections are 
rising at an alarming pace and attaching 
antibiotics directly to biomaterials might 
constitute an interesting therapeutic ap-
proach.
[1]  a) S. Bonazzi, S. Güttinger, I. Zemp, U. Kutay, 
K. Gademann, Angew. Chem. Int. Ed. 2007, 46, 
8707; b) S. Bonazzi, O. Eidam, S. Güttinger, J.-
Y. Wach, I. Zemp, U. Kutay, K. Gademann, J. 
Am. Chem. Soc. 2010, 132, 1432.
[2]  J.-Y. Wach, S. Güttinger, U. Kutay K. 
Gademann, Bioorg. Med. Chem. Lett. 2010, 20, 
2843.
[3]  a) P G. Becher, J. Beuchat, K. Gademann, F. 
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Barbaras, M. Kaiser, R. Brun, K. Gademann, 
Bioorg. Med. Chem. Lett. 2008, 18, 4413; c) S. 
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P. Schneider, S. T. Cole, M. Kaiser, R. Brun, K. 
Gademann, Bioorg. Med. Chem. 2010, 18, 1464.
[4]  a) C. Portmann, J. F. Blom, K. Gademann, F. 
Jüttner, J. Nat. Prod. 2008, 71, 1193; b) C. 
Portmann, J. F. Blom, F. Jüttner, K. Gademann, 
J. Nat. Prod. 2008, 71, 1881.
[5]  H. J. Jessen, D. Barbaras, M. Hamburger, K. 
Gademann, Org. Lett. 2009, 11, 3446.
[6]  S. Zürcher, D. Wäckerlin, Y. Bethuel, B. 
Malisova, M. Textor, S. Tosatti, K. Gademann, 
J. Am. Chem. Soc. 2006, 128, 1064.
[7]  J.-Y. Wach, B. Malisova, S. Bonazzi, S. Tosatti, 
M. Textor, S. Zürcher, K. Gademann, Chem. 
Eur. J. 2008, 14, 10579.
[8]  a) S. Saxer, C. Portmann, S. Tosatti, 
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Pieles, M. Elsener, M. Horisberger, S. Tosatti, 
M. Textor, K. Gademann, S. Zürcher, Prog. 
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Electron Transfer in 
Biopolymers
Bernd Giese
Long-range electron transfer (ET) plays 
an important role in biological systems. 
In the 1990s the question was raised: how 
do electrons travel 
over very long dis-
tances (up to 30 nm 
in DNA) through 
biopolymers? Ac-
cording to the Mar-
cus theory ET rates 
decrease exponen-
tially with distance, 
thus ET over more than 2 nm in biopoly-
mers cannot occur by a single-step reaction 
(superexchange mechanism). The Giese 
group has solved the problem by showing 
that ET takes place in a multistep reac-
tion (hopping mechanism). The stepping-
stones in DNA are the heterocyclic bases. 
For an oxidative process, where a radical 
cation migrates through DNA the purines 
can carry the charge. Guanine (G) is the 
preferred charge carrier because it is more 
easily oxidizable than adenine (A), and the 
charge hops between the Gs in a superex-
change mechanism, if the intervening A:T 
sequence is short (G-hopping).[1] If the A:T 
sequence is more than 1 nm long this G-
hopping step is so slow that the adjacent A 
becomes oxidized and the charge also uses 
the As as stepping stones (A-hopping).[2,3] 
For a reductive process the pyrimidines are 
the stepping stones for the radical anion. 
Because of similar reduction potentials 
both thymine (T) and cytosine (C) act as 
stepping-stones. Excess electrons repair 
UV-induced DNA lesions, and it was found 
that one electron acts as a catalyst, cleaving 
several DNA lesions.[4]
After the basic principles of long-range 
 
Fig. 1. Natural products interfering with biological systems.
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ET through DNA were understood, the 
Giese group posed the question whether 
a hopping process can also explain long-
range ET in proteins (Fig. 1). Nature uses 
this reaction in energy conversion pro-
cesses as well as in enzymatic catalysis. In 
proteins the side-chains of certain amino 
acids might act as stepping-stones. A pep-
tide assay was developed where the elec-
tron acceptor (A) was generated as a radi-
cal cation by a laser flash.[5] This electron 
accepter triggers the electron transfer from 
the donor (D), and the function of the inter-
mediate amino acid, carrying side chain X 
could be measured. Using this assay Giese 
and his group showed: a) a stepwise pro-
cess is faster then a one-step reaction,[6] b) 
only certain amino acids can act as stepping 
stones, which were called relay amino ac-
ids,[7] c) ET rates depend upon the direction 
along the peptide,[8] d) charges at the pep-
tides (ammonium and carboxylate groups) 
influence the ET rate,[9] and e) neighbor-
ing groups can influence the efficiency of 
amino acids as stepping-stones.[8]
[1]  E. Meggers, M. E. Michel-Beyerle, B. Giese, J. 
Amer. Chem Soc. 1998, 120, 12950. 
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Ed. 2004, 43,1848.
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M. Graber, J. Org. Chem. 2009, 74, 3621.
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lecular biology. It was anticipated that ap-
pending an organometallic moiety to biotin 
by means of an amide to the valeric acid 
side chain of biotin would ensure local-
ization of the catalyst within (strept)avi-
din, thus providing a well defined second 
coordination sphere. Circular dichroism 
(CD) titrations revealed: i) the presence of 
induced-CD signals, suggesting the pres-
ence of a well-defined chiral environment 
around the metal center and ii) markedly 
reduced affinities ranging from (106 M–1 < 
K
a 
< 109 M–1).[6] Such affinities, however, 
ensure that under reaction conditions – 
with [catalyst] > 20 mM – nearly all of the 
catalyst is bound to (strept)avidin, thus al-
leviating the need for covalent anchoring 
of the metal moiety to the host protein.
After many unsuccessful attempts us-
ing avidin as host protein, a breakthrough 
occurred upon switching to streptavidin 
(Sav hereafter). Hydrogenation of N-acet-
amidoacrylic acid yielded up to 94% ee in 
favor of the (R)-enantiomer (Scheme 1).[7]
Having established the proof-of-prin-
ciple, the Ward group focused on vari-
ous aspects of artificial metalloenzymes. 
Among these they have: i) implement-
ed robust optimization protocols,[8] ii) 
strived to improve the turnover numbers 
and turnover frequencies,[9] iii) applied 
this approach to other enantioselective 
transformations, iv) extended the concept 
to other recognition events and v) exploit-
ed other anchoring strategies as well as 
other host proteins.
Fig. 1. 
In the past, homo-
geneous and enzy-
matic catalysis have 
grown independent-
ly with very little 
interaction between 
the respective fields. 
To many scientists 
both approaches 
seemed complementary but not compat-
ible with each other.[1] Thanks to the pio-
neering efforts of Bäckvall and co-workers 
on combining hydrolytic enzymes with 
organometallic catalysts for the dynamic 
kinetic resolution of alcohols,[2] it ap-
peared that organometallic catalysis may 
not be incompatible with proteins. Fasci-
nated by the exquisite levels of selectivity 
and  activity achieved by many enzymes, 
Thomas Ward speculated that incorpora-
tion of a catalytically competent organo-
metallic moiety within a protein scaffold 
may afford artificial metalloenzymes with 
properties reminiscent of both homoge-
neous and enzymatic systems (Fig. 1).[3]
Initial attempts to localize the metal 
moiety within a protein were based on a 
covalent attachment.[4] However, it became 
rapidly clear that a supramolecular anchor-
ing strategy may be more straightforward. 
Inspired by Whitesides,[5] we turned to the 
biotin-avidin technology to create hybrid 
catalysts (Fig. 1). 
Thanks to the very high affinity of bio-
tin for either avidin or streptavidin ((strept)
avidin hereafter, K
a 
> 1013 M–1), this system 
– commonly coined ‘molecular velcro’ – 
has found widespread applications in mo-
Artificial Metalloenzymes: Enantioselective Catalysis 
and Beyond
Thomas R. Ward
Fig. 1. a) Summary of the pros and cons of 
homogeneous and enzymatic catalysts;  
b) artificial metalloenzymes based on anchoring 
an organometallic moiety within a protein 
scaffold. Variation of the spacer (oval) and 
the chelating ligand (chemical optimization) is 
combined with genetic modification (star) of 
the host protein (via its gene), thus affording a 
versatile chemo-genetic optimization strategy.
a) Homogeneous Enzymatic
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Perhaps one of the most versatile fea-
tures of artificial metalloenzymes relies 
on the fact that both chemical and genetic 
optimization protocols can be exploited to 
improve the performance of the hybrid cat-
alyst.[10] In most cases, the chemical opti-
mization such as using a conformationally 
rigid biotin spacer containing enantiopure 
amino acids[9,11] has a larger impact on the 
performance of the hybrid catalyst than 
exchange of an amino acid of the protein. 
The latter variation can be regarded as a 
fine tuning step.
This insight led to an expansion of 
Ward’s research ranging from asymmetric 
transfer hydrogenation of prochiral ketones 
and imines, catalyzed by d6 piano-stool 
complexes (Scheme 2);[12] and palladium-
catalyzed asymmetric allylic alkylation 
(Scheme 3)[13] towards oxidation reactions 
including the vanadyl-catalyzed sulfoxi-
dation of prochiral sulfides (Scheme 4)[14] 
and the dihydroxylation of olefins.
The X-ray structure of [(η6-arene)
Ru(biot-en)Cl]⊂Sav revealed two interest-
ing aspects: i) the metal complex is located 
in the biotin-binding vestibule and ii) the 
metal complex is surrounded by positively 
charged surface areas (Fig. 2b). Hence, it 
seemed intriguing to explore the recog-
nition of this exposed positively charged 
surface with negatively charged proteins 
or nucleotides, and investigate possible 
interactions of the embedded metal com-
plex with such macromolecular targets. 
To probe this interaction for example with 
glutathione and various forms of DNA, 
isothermal titration calorimetry and elec-
trophoretic mobility shift assays were per-
formed using as a control the biotinylated 
piano-stool complexes [(η6-arene)Ru(biot-
en)Cl] derived from the well-known 
‘Sadler-type’ complexes.[15] 
First results of Ward’s group are very 
encouraging: i) the ternary complex [(η6-
arene)Ru(biot-en)Cl]⊂Sav·DNA is much 
more stable than either Sav·DNA or [(η6-
arene)Ru(biot-en)Cl]·DNA; ii) tel-DNA is 
recognized preferentially over ds-DNA; 
iii) chemogenetic optimization can be 
used to modulate the affinity of [(η6-arene)
Ru(biot-en)Cl]⊂Sav towards its target; 
charged amino acid residues in the vicin-
ity of the metal play a critical role in de-
termining the affinity towards negatively 
charged DNA;[16] iv) neither streptavidin 
nor the biotinylated complex display high 
affinities towards ds-DNA or telomeric-
DNA (tel-DNA); v) The presence of com-
peting targets such as gluthatione does not 
prevent the binding towards tel-DNA: [(η6-
arene)Ru(biot-en)Cl]⊂Sav·tel-DNA.
Another offspring of Ward’s research 
concerning streptavidin-biotin conjugates 
relates to mimetics of collagen that are fi-
ber proteins supporting the biomineraliza-
tion of hydroxyapatite for bone calcifica-
Scheme 1. Artificial 
hydrogenases for 
the enantioselective 
reduction of 
N-protected 
dehydroamino acids. 
Chemo-genetic 
optimization affords 
both (R)- and (S)-
reduction products.
Scheme 2. Selected 
results for artificial 
metalloenzymes based 
on the biotin-avidin 
technology for the 
asymmetric transfer 
hydrogenation of 
ketones.
Scheme 3. Selected 
results for artificial 
alkylases based on 
the biotin-avidin 
technology.
Scheme 4. Selected 
results for artificial 
sulfoxidases based 
on the non-covalent 
incorporation of a 
vanadyl moiety within 
streptavidin. See ref. 
[14a] for the aviloop 
sequence.
852  CHIMIA 2010, 64, No. 12  550th AnniversAry of the University of BAsel
tion. To construct a collagen mimic, well-
defined protein aggregates are required, 
and it was speculated such polymers could 
be constructed using the homotetrameric 
nature of Sav. Accordingly, a bis-biotinyl-
ated anchor was prepared to ensure that 
both biotin anchors bind to a single Sav 
tetramer in a cis-fashion.[17] 
Two such bis-biotin anchors can be 
linked thanks to the presence of a terpy-
ridine moiety which binds cooperatively 
to form [Fe(terpyridine)2]2+, thus creat-
ing a streptavidin thread (Fig. 3a). The 
structure of this ‘Protein Organo-Metallic 
Framework’ (POMF) was investigated by 
surface plasmon resonance revealing a 
one-dimensional polymer. Since strepta-
vidin carries 48 carboxylate residues on 
its surface, the addition of Ca2+ leads to 
the formation of protein bundles (Fig. 3b) 
as revealed by electron microscopy. Upon 
addition of both Ca2+ and CO2, these fi-
bers template the biomineralization of 
calcite (Fig. 3).[18]
Fig. 2. a) The protein display strategy applied to [(η6-arene)Ru(biot-en)Cl]⊂Sav for the selective 
recognition of tel-DNA and b) close-up view of the X-ray structure of [(η6-cymene)Ru(biot-en)
Cl]⊂Sav revealing a positively charged shallow surface (blue) around the metal favoring extensive 
interactions with target DNA.
Fig. 3. a) Protein 
Organo-Metallic 
Frameworks based 
on the biotin-avidin 
technology; b) in the 
presence of calcium, 
the Sav polymer forms 
bundles as revealed 
by SEM; c) adding 
Ca2+ and CO2 leads to 
the biomineralization 
of calcite on the Sav 
bundles.
Acknowledgements
The research projects of Thomas Ward 
are supported by the Swiss National Science 
Foundation (Grants FN 200020-113348 and 
200020-126366), the Canton of Basel as well as 
the Marie Curie Training Networks IBAAC and 
BIOTRAINS (FP6-MRTN-CT-2003-505020 
and FP7-ITN-238531). His group enjoys 
cooperations with Prof. Tilman Schirmer 
(Biozentrum) for the structural characterization 
of hybrid catalysts, Prof. Markus Meuwly for 
the in silico design of artificial metalloenzymes, 
Prof. Wolfgang Meier towards in vivo catalysis 
as well as Prof. Daniel Gygax and Prof. Uwe 
Pieles (FHNW) for the characterization of the 
POMFs.
[1]  T. R. Ward, Chem. Eur. J. 2005, 11, 3798.
[2]  O. Pàmies, J.-E. Bäckvall, Chem. Rev. 2003, 
103, 3247.
[3]  A. Pordea, T. R. Ward, Chem. Commun. 2008, 
4239.
[4]  S. Duclos, T. R. Ward, H. Stoeckli-Evans, Helv. 
Chim. Act. 2001, 84, 3148.
[5]  M. E. Wilson, G. M. Whitesides, J. Am. Chem. 
Soc. 1978, 100, 306.
[6]  a) A. Loosli, U. E. Rusbandi, J. Gradinaru, 
K. Bernauer, C. W. Schläpfer, M. Meyer, S. 
Mazurek, M. Novic, T. R. Ward, Inorg. Chem. 
2006, 45, 660; b) M. Skander, N. Humbert, J. 
Collot, J. Gradinaru, G. Klein, A. Loosli, J. 
Sauser, A. Zocchi, F. Gilardoni, T. R. Ward, J. 
Am. Chem. Soc. 2004, 126, 14411.
[7]  J. Collot, J. Gradinaru, N. Humbert, M. Skander, 
A. Zocchi, T. R. Ward, J. Am. Chem. Soc. 2003, 
125, 9030.
[8]  M. Creus, T. R. Ward, Org. Biomol. Chem. 
2007, 5, 1835.
[9] U. E. Rusbandi, C. Lo, M. Skander, A. Ivanova, 
M. Creus, N. Humbert, T. R. Ward, Adv. Synth. 
Catal. 2007, 349, 1923.
[10]  G. Klein, N. Humbert, J. Gradinaru, A. Ivanova, 
F. Gilardoni, U. E. Rusbandi, T. R. Ward, 
Angew. Chem. Int. Ed. 2005, 44, 7764.
[11]  M. Skander, C. Malan, A. Ivanova, T. R. Ward, 
Chem. Commun. 2005, 4815.
[12]  a) M. Creus, A. Pordea, T. Rossel, A. Sardo, 
C. Letondor, A. Ivanova, I. LeTrong, R. E. 
Stenkamp, T. R. Ward, Angew. Chem. Int. Ed. 
2008, 47, 1400; b)A. Pordea, M. Creus, C. 
Letondor, A. Ivanova, T. R. Ward, Inorg. Chim. 
Acta 2010, 363, 601.
[13]  J. Pierron, C. Malan, M. Creus, J. Gradinaru, 
I. Hafner, A. Ivanova, A. Sardo, T. R. Ward, 
Angew. Chem. Int. Ed. 2008, 47, 701.
[14]  a) A. Pordea, M. Creus, J. Panek, C. Duboc, 
M. Novic, D. Mathis, T. R. Ward, J. Am. Chem. 
Soc. 2008, 130, 8085; b)A. Pordea, D. Mathis, 
T. R. Ward, J. Organomet. Chem. 2009, 694, 
930.
[15]  Y. K. Yan, M. Melchart, A. Habtemariam, P. J. 
Sadler, Chem. Commun. 2005, 4764.
[16]  M. J. Zimbron, A. Sardo, T. Heinisch, T. 
Wohlschlager, J. Gradinaru, C. Massa, T. 
Schirmer, M. Creus, T. R. Ward, Chem. Eur. J. 
2010, 16, 12883.
[17]  K. J. Hamblett, B. B. Kegley, D. K. Hamlin, 
M. K. Chyan, D. E. Hyre, O. W. Press, D. S. 
Wilbur, P. S. Stayton, Bioconjugate Chem. 
2002, 13, 588.
[18]  S. Burazerovic, J. Gradinaru, J. Pierron, T. R. 
Ward, Angew. Chem. Int. Ed. 2007, 46, 5510.
b)a)
a)
550th AnniversAry of the University of BAsel  CHIMIA 2010, 64, No. 12  853
Research of the Woggon group is focused 
on new enzymes, enzymatic reaction 
mechanisms and the synthesis of inhibitors 
and catalytically competent enzyme mod-
els. In this context the group has discovered 
two enzymes related to the biosynthesis of 
vitamins (Scheme 1): i) a non-heme iron 
protein (60.3 kD) catalyzing the central 
cleavage of b-carotene 1 to retinal 2[1,2] and 
the enzyme tocopherol cyclase (41.3 kD) 
which cyclizes phytylhydroquinones such 
as 3 to γ-tocopherol 4, one of the members 
of vitamin E compounds.[3]
The reaction mechanisms of these en-
zymatic transformations were elucidated 
revealing that the reaction 1 → 2 is in agree-
ment with a monooxygenase formalism[4] 
whereas the ring closure of 3 → 4 proceeds 
by si protonation of the double bond and 
concomitant re attack of the phenol.[3] Cor-
responding enzyme mimics were prepared, 
for example the bis-b-cyclodextrin-Ru por-
phyrin 5 contains a perfect supramolecular 
binding site for hydrophobic carotenoids (K
a 
= 8 × 106 M–1) and ruthenium porphyrin that 
in the presence of tert-butyl hydroperox-
ide (TBHP) becomes reactive to cleave the 
central E-configured double bond of carot-
enoids (Scheme 2).[5] The design of enzyme 
mimic 6 takes into account that the enzyme 
tocopherol cyclase binds the substrate in a 
particular conformation in order to allow 
for the enantioface-selective protonation of 
the phytyl double bond by a weakly acidic 
amino acid. From compound 6 α-tocopherol 
can be obtained with 78% de.[6]
Another long-lasting project of the 
Woggon group relates to the significance of 
heme-thiolate proteins such as cytochrome 
P450 and chloroperoxidase (CPO).[7] Sev-
eral enzyme models were synthesized (7–
11, Fig. 1.) to understand the importance of 
the unusual thiolate ligand with respect to 
chemical reactivity, redox potential of the 
system and spin state changes during the 
catalytic cycle. 
From these investigations catalytically 
competent complexes such as 9 emerged 
and recently the complete catalytic cycle 
of cytochromes P450 including several in-
termediates could be observed by stopped-
flow techniques.[8]
It is interesting to note that 7 is the first 
P450 model compound that displays the 
exceptional reactivity towards non-activat-
ed C–H bonds, i.e. one of the CH2 groups 
of the alkane bridge is hydroxylated by the 
Fe(iv)=O complex generated by reacting 7 
with PhIO. However, the redox potentials 
of 7 and the corresponding cyclohexyl 
thiolate complex 8 are rather negative (E
o 
> –600 mV) as compared to the E.S com-
plex of the enzyme P450
cam
 (E
o
= –170 mV) 
This situation changes when the thiolate is 
replaced by a sulfonate group, the E
o
-value 
of 9 is –175 mV, moreover 9 is a rather 
robust catalyst for P450-like oxidations. 
The complexes 10 and 11 have been pre-
pared to understand why the resting state 
of cytochrome P450
cam
 (-S-….Fe(III)….
OH2-cluster) is a low-spin system. EPR 
measurements revealed that 10 is a high-
spin complex whereas for 11, that offers 
H-bonding to the water molecule bound to 
Fe(iii), a low-spin compound was detected. 
It was concluded that the low-spin char-
acter of P450
cam
 is due to polarization of 
the distal water cluster rendering the water 
directly coordinating to iron HO–-like.[7]
Chloroperoxidase (CPO) is a very ver-
satile heme-thiolate protein that inter alia 
halogenates substrates. The mechanism of 
halogenation was poorly understood until 
the Woggon group prepared enzyme mod-
els such as 12 (Fig. 2), and spectroscopi-
cally identified adducts 13 and 14 of which 
the latter is a catalytically competent re-
agent halogenating activated C–H bonds.[7] 
Due to this information corresponding 
intermediates of the enzymatic reac-
tion could be identified using CPO from 
Caldariomyces fumago. 
In all organisms cytochrome P450 iso-
zymes play an important role in the metab-
olism of exogenous and endogenous com-
pounds, notably in human organs such as 
Scheme 1. Enzymes 
signifi cant to vitamin 
A and vitamin E 
formation.
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liver and lungs. Of particular interest is the 
fact that ca. 50% of drugs are metabolized 
by CYP 3A4, one of the P450 enzymes in 
human liver accounting for a large num-
ber of documented drug–drug interactions 
associated with CYP 3A4 inhibition. The 
aim of Woggon’s research in this area was 
the development of compounds blocking 
the different binding sites of CYP 3A4 
such that the affinity of drug candidates 
could be evaluated by displacement of a 
single probe without performing tedious 
enzyme inhibition studies. Favourably 
these compounds display a IC50 between 
1–10 mM which is considered to be a cut-
off value to eliminate drugs binding too 
strongly to CYP 3A4. These features were 
accomplished using the synthetic steroid 
derivative 15 of which the fluorescence of 
the deazaflavin chromophore is quenched 
on binding to the heme-thiolate cofactor of 
CYP 3 A4 (see 16, Scheme 3).[9] IC50 val-
ues of 15 are in the desired range between 
1–4 mM. Hence this method can be used to 
rapidly screen a series of drug candidates 
identifying compounds whose high affin-
ity to CYP 3A4 may lead to dangerous 
drug–drug interactions when administered 
together with other CYP 3A4 substrates.
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